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Cytokines, small proteins released by the immune system to combat infection, are typically studied under inflammatory conditions.
However, these molecules are also expressed in the brain in basal, nonpathological states, where they can regulate neuronal processes,
such as learning and memory. However, little is known about how cytokine signaling in the brain may influence higher-order cognitive
functions. Cognitive flexibility is one such executive process, mediated by the prefrontal cortex, which requires an adaptive modification
of learned behaviors in response to environmental change. We explored the role of basal IL-6 signaling in the orbitofrontal cortex (OFC)
in reversal learning, a form of cognitive flexibility that can be measured in the rat using the attentional set-shifting test. We found that
inhibiting IL-6 or its downstream JAK/STAT signaling pathway in the OFC impaired reversal learning, suggesting that basal IL-6 and
JAK/STAT signaling facilitate cognitive flexibility. Further, we demonstrated that elevating IL-6 in the OFC by adeno-associated virus-
mediated gene delivery reversed a cognitive deficit induced by chronic stress, thus identifying IL-6 and the downstream JAK/STAT
signaling pathway as potentially novel therapeutic targets for the treatment of stress-related psychiatric diseases associated with cogni-
tive dysfunction.
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Introduction
Cognitive flexibility, the ability to modify previous learning in
response to environmental change, is critical for adaptive behav-
ior. Reversal learning is one form of cognitive flexibility, requir-
ing subjects to switch cue-directed operant responding from a
previously positive stimulus that is now negative to a previously
negative stimulus that is now associated with reward. Reversal
learning deficits have been associated with psychiatric diseases,
including schizophrenia (Leeson et al., 2009), obsessive– com-
pulsive disorder (Remijnse et al., 2006), and depression (Must et
al., 2006). Optimal reversal learning depends on the functional
integrity of the orbitofrontal cortex (OFC) and the dorsal stria-
tum (Clarke et al., 2008), and monoaminergic neurotransmitters,
including serotonin, can modulate reversal learning (Clarke et
al., 2004; Lee et al., 2007; DeSteno and Schmauss, 2009; Lapiz-
Bluhm et al., 2009). In addition to monoamines and other tradi-
tional neurotransmitters, increasing evidence suggests that
immune signaling molecules (e.g., cytokines) can also modulate
synaptic plasticity and cognition in the brain. The pleiotropic
cytokine, interleukin-6 (IL-6), which has both proinflammatory
and anti-inflammatory actions, also plays a complex role in reg-
ulating cognitive function (Yirmiya and Goshen, 2011). A grow-
ing literature suggests that stress can increase cytokine levels
(Steptoe et al., 2007; Jankord et al., 2010) and that excessive IL-6
signaling induced by aging or inflammation may impair cogni-
tive processes, such as spatial learning and memory (Sparkman et
al., 2006; Dugan et al., 2009). In humans, elevated IL-6 has been
correlated with age-related cognitive decline (Weaver et al.,
2002), and plasma IL-6 strongly predicts the cognitive symptoms
of depression (Gimeno et al., 2009).
Based on these observations, we set out to determine whether
IL-6 signaling can modulate reversal learning, with the a priori
hypothesis that IL-6 may contribute to a selective reversal learn-
ing deficit induced by chronic cold stress (Lapiz-Bluhm et al.,
2009). However, in the first experiment, we found that blocking
IL-6 actually impaired reversal learning in both stressed and non-
stressed animals, suggesting that basal IL-6 signaling in the brain
(i.e., in the absence of stress or inflammation) may instead facil-
itate cognitive function. Indeed, results of other studies have
shown that IL-6 is not universally detrimental for cognition
(Yirmiya and Goshen, 2011). For example, in young, healthy
animals, exogenous IL-6 administration has no effect (Oitzl et al.,
1993), and genetic IL-6 knock-out actually impairs performance
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on spatial learning tasks (Braida et al., 2004). Further, in animals
compromised by treatment with scopolamine or ischemia, IL-6
improved memory function (Matsuda et al., 1996; Braida et al.,
2004). Thus, in subsequent experiments, we explored the role of
basal IL-6 signaling in modulating reversal learning. We first lo-
calized the effect of IL-6 to the OFC and demonstrated that,
under basal conditions, IL-6 is expressed primarily by neurons in
the OFC. We then tested the JAK/STAT signaling pathway as a
potential mechanism by which IL-6 facilitates reversal learning.
Finally, because endogenous IL-6 facilitates reversal learning, we
then tested the hypothesis that chronic overexpression of IL-6, or
acute microinjection of exogenous IL-6 into the OFC, would
attenuate a reversal learning deficit caused by chronic stress.
Materials and Methods
Animals. A total of 147 adult male Sprague Dawley rats (Harlan,
220 –240 g) were maintained on a 12 h/12 h light/dark cycle, with food
and water available ad libitum. All procedures were consistent with
National Institutes of Health guidelines (National Institutes of Health
publications no. 80-23, revised 1978) and approved by the Institu-
tional Animal Care and Use Committee of the University of Texas
Health Science Center at San Antonio.
Chronic intermittent cold (CIC) stress. Rats were moved in their home
cage into a 4°C cold room for 6 h per day for 14 consecutive days. Con-
trols remained in housing for the same period of time.
Stereotaxic surgeries. Guide cannulae or injectors were inserted stereo-
taxically, targeting the OFC (from bregma: AP 2.9, ML 2.6, DV 5.2),
dorsal striatum (AP 1.2, ML 2.8, DV 5.0), or lateral ventricles (AP
0.9, ML 1.4, DV 4.5; Paxinos and Watson, 2006). After surgery,
animals recovered for at least 5 d before any experimental procedures.
Cannula placement was confirmed histologically for all animals.
Adeno-associated virus (AAV) production. To generate a constitutively
secreted, functional IL-6 construct, the IL-1 receptor antagonist signal
peptide sequence was fused to the 5 end of the IL-6 mature peptide
sequence, based on previous work (Wingren et al., 1996). Nested PCR
was performed as follows: First, the human IL-6 mature peptide sequence
was amplified for 20 cycles using a forward primer containing the 3
portion of the human IL-1 receptor antagonist signal peptide immedi-
ately adjacent to and in frame with the 5 portion of human IL-6 mature
peptide sequence: tcctcttcctgttccattcagagacgatctgc*gccccagtacccccagg,
where * represents the location of the linked sequences; a reverse primer
for the human IL-6 mature peptide: actagcggccgcgatatcctacattt, contain-
ing an EcoR1 restriction site; and a template human IL-6 coding se-
quence cassette (NCBI accession: BC015511, Thermo Scientific clone ID:
MHS6278 –202756684). A second PCR amplification was performed for
30 cycles using the purified first amplification product and the forward
primer: accggtgccaccatcagtaaccggtgccaccatggaaatctgcagaggcctccgcagtca
cctaatcactctcctcctcttcctgttcc, containing an Age1 restriction site followed
by a Kozak sequence and the 5 coding sequence of human IL-1 receptor
antagonist signal peptide. The sequence-verified PCR product was di-
gested with EcoR1 and Age1 enzymes and subcloned into an AAV termi-
nal repeat-containing cassette, behind a hybrid chicken  actin promoter
(Gray et al., 2011). Virus was produced in HEK-293 cells as previously
described (Grieger et al., 2006; Johnson et al., 2010). Briefly, polyethyl-
enimine (linear molecular weight, 25,000) was used for triple transfec-
tion of the pXR2/pXR5 rep and cap plasmid, the pXX6 – 80 helper
plasmid, and the IL-6 fusion product or the control GFP expression
cassette flanked by inverted terminal repeats. At 72 h after transfection,
cells were harvested and virus was purified by dual cesium chloride den-
sity gradient centrifugation. Peak fractions of AAV were dialyzed into 1
PBS and 5% sorbitol. Titers were calculated by quantitative PCR accord-
ing to established procedures (Johnson et al., 2010) using a LightCycler
480 using TaqMan PCRmix (Applied Biosystems) and primers designed
against the SV40 polyA sequence: (forward) 5-AGCAATAGCATC-
ACAAATTTCACAA-3, and (reverse) 5-CCAGACATGATAAGA-
TACATTGATGAGTT-3, along with a dual-labeled probe: 5-fam
AGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTC-3-tamra (Inte-
grated DNA Technologies).
Attentional set-shifting test. The attentional set-shifting test (AST) was
performed as described previously (Danet et al., 2010; Furr et al., 2012).
Briefly, 7 d before testing, rats were restricted to 14 g food/d, with ad
libitum access to water. Rats were trained to dig in terracotta pots to
receive a 1⁄4 Honey Nut Cheerio reward. The pots were defined by cues
along two stimulus dimensions: the digging medium filling the pot and
an odor applied to the inner rim of the pot. During testing, the “positive”
pot was baited with reward buried within the digging medium. Each stage
of testing required a different discrimination, with a criterion of six con-
secutive correct trials required to proceed to the next stage. The first stage
was a simple discrimination, with only one stimulus dimension (odor or
medium) present. The second stage was a compound discrimination in
which the same discrimination was required and the second irrelevant
dimension was introduced as a distractor. The third stage was the reversal
learning task. The same odors and media were used, and the relevant
dimension (odor or medium) remained the same, but the negative cue
from the previous stage was now positive, and the positive cue from the
previous stage was now negative. The dependent measure was the num-
ber of trials to criterion on the reversal learning stage. Animals that did
not dig within 10 min on six consecutive trials or that did not meet
criterion within 50 trials on any test stage were excluded from analysis.
Tissue collection. For the OFC, a 2 mm coronal section was cut from
2 to 4 mm caudal to the frontal pole. From this coronal slab, a wedge
of tissue was dissected from the lateral margin of the brain to the
medial boundary of the forceps minor, ventral to the forceps minor
and dorsal to the rhinal sulcus.
ELISA. Total homogenates were prepared in Invitrogen Tissue Extrac-
tion Reagent I with protease and phosphatase inhibitors (Sigma) and
used to measure rat and human IL-6 by ELISA (Invitrogen) according to
the manufacturer’s instructions. IL-6 levels were normalized to total pro-
tein, as determined by the Bradford assay.
Western blot. Tissue homogenates were prepared as above, and equal
amounts of protein were subjected to SDS-PAGE and transferred to
PVDF membrane (Immobilon P, Millipore). The following primary an-
tibodies (Cell Signaling Technology) were used: phospho-STAT3 (Tyr
705; 1:1000), phospho-ERK1/2 (Thr202/Tyr204; 1:10,000), phospho-
AKT (Ser473; 1:5000), and phospho-AKT (Thr308; 1:3000). After incu-
bation with an HRP-linked secondary antibody (Cell Signaling
Technology) and Prime ECL detection reagent (GE Healthcare), blots
were stripped and reprobed with a STAT3 antibody (Santa Cruz Biotech-
nology, sc-8019; 1:1000), ERK1/2 antibody (Santa Cruz Biotechnology,
sc-94; 1:50,000), or AKT antibody (Cell Signaling Technology; 1:80,000),
which were used to normalize the corresponding phospho-protein
signals.
Immunohistochemistry. Rats were anesthetized and perfused tran-
scardially with 4% paraformaldehyde. Dual-label fluorescence immu-
nohistochemistry was performed sequentially on free-floating 40 m
sections through the OFC. For antigen retrieval and peroxide quench-
ing, sections were boiled in 10 mM citric acid, pH 6. The following
primary antibodies were used: GFAP (Cell Signaling Technology,
1:500), CD11b (AbD Serotec, 1:500), Iba1 (Millipore, 1:5000), NeuN
(Millipore, 1:500), IL-6 (Santa Cruz Biotechnology, M19, 1:250), GFP
(Millipore, 1:15,000), or phospho-STAT3 (1:100,Cell Signaling Tech-
nology). After incubation with biotinylated secondary antibodies (GE
Healthcare, Sigma), sections were incubated with an avidin-
peroxidase conjugate (Vectastain ABC, Vector Laboratories) and
then Tyramide Signal Amplification Cy3 reagent for the cell markers,
and fluorescein reagent for IL-6 and phospho-STAT3 (PerkinElmer).
Sections were mounted on gelatin-coated slides, coverslipped with
Vectashield mounting media (Vector Laboratories), and then imaged
using an Olympus IX81 Motorized Inverted microscope. Digital im-
ages were acquired using FV10-ASW software and enhanced using
ImageJ.
Statistics. Animals were randomly assigned to treatment groups. In all
figures, data are shown as mean  SEM and n is indicated in the figure
legend. For Experiment 2, trials to meet criterion (TTC) on the reversal
learning stage of the AST were analyzed using Student’s t test. For all
other experiments, TTC, IL-6 protein levels, phospho-STAT3, phospho-
ERK1/2, and phospho-AKT levels were analyzed by two-way ANOVA.
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The Bonferroni post hoc test was used when interactions or main effects
were significant. All tests were two-tailed, and significance was deter-
mined at p  0.05.
Experiment 1: effect of chronic immunoneutralization of brain IL-6 on
reversal learning. To test the hypothesis that IL-6 contributes to the deficit
in reversal learning induced by CIC stress, we administered a neutralizing
polyclonal goat anti-rat IL-6 antibody or normal goat IgG (R&D Sys-
tems) as control to CIC-stressed or unstressed control animals. Intrace-
rebroventricular antibody administration has been shown to penetrate
the brain parenchyma and affect behavior (Balschun et al., 2004; Palin et
al., 2009). Therefore, osmotic minipumps (Alzet model 1004; flow rate
2.64 l/d), filled with anti-IL-6 antibody or normal goat IgG, diluted in
saline to a concentration calculated to deliver 400 ng/d, were implanted
subcutaneously. This dose has been shown to effectively block LPS-
induced changes in neuronal function (Palin et al., 2009). Dual-injection
cannulae (Plastics One), connected to the minipumps by plastic tubing,
were implanted into the lateral ventricles. After 5 d recovery, animals
were randomly assigned to CIC stress or nonstress control groups. Three
days after the end of stress, or at the equivalent time point for controls,
rats were tested on the AST. After completion of the test, the OFC was
collected and STAT3, ERK1/2, and AKT phosphorylation was measured
by Western blot.
Experiment 2: effect of acute IL-6 immunoneutralization in OFC on
reversal learning. To identify the brain region responsible for the detri-
mental effect of chronic IL-6 neutralization on reversal learning seen in
Experiment 1, rats were implanted with bilateral guide cannulae (22-
gauge stainless-steel, 11 mm length) with their tips 1 mm above either the
OFC or dorsal striatum. After 2 weeks recovery, rats were tested on the
AST. Upon completion of the compound discrimination task, obdura-
tors were removed and microinjectors (30-gauge stainless steel) were
inserted, extending 1 mm beyond the cannula tips. Microinjectors were
connected by a fluid-filled line to a Hamilton syringe mounted on a
syringe pump (Instech Laboratories). IL-6 antibody or control IgG was
injected bilaterally (50 ng/0.5 l saline vehicle in OFC, 100 ng/1.0 l in
dorsal striatum) at a rate of 0.25 l/min. The concentration of antibody
was similar to that used in Experiment 1, the assumption being that if this
concentration was effective with intracerebroventricular delivery, it
should also be effective delivered directly into the OFC or dorsal stria-
tum. Injectors remained in place 3 min to allow for diffusion before
removing. Five minutes after injection, testing resumed with the reversal
learning task. Polyclonal goat IgG injected intravenously takes 63 h to
degrade by half, suggesting that the antibody was active throughout the
reversal learning test (Peppard and Orlans, 1980).
Experiment 3: effect of chronic IL-6 overexpression in the OFC on the CIC
stress-induced reversal learning deficit. To determine whether elevating
IL-6 in the OFC attenuates the reversal learning deficit caused by CIC
stress, an AAV was used to overexpress either human IL-6 (AAV-IL-6) or
green fluorescent protein (AAV-GFP), as a control. The pseudotyped
AAV2/5 (AAV2 vector within AAV5 capsid) has been shown to exclu-
sively infect neurons throughout the brain, producing stable gene expres-
sion (Burger et al., 2004). Rats were anesthetized and placed in a
stereotaxic frame. Microinjectors were lowered into the OFC. AAV-IL-6
or AAV-GFP (6.9  10 7 viral genomes/l) was injected in 0.5 l saline
per side, at a rate of 0.25 l/min. This viral dose was chosen based on pilot
studies demonstrating a threefold to fourfold increase in IL-6 expression
and activation of downstream signaling pathways, without approaching
levels seen under inflammatory conditions (Harting et al., 2008). Injec-
tors were left in place for 3 min to allow diffusion. After 5 d recovery,
animals were exposed to CIC stress for 2 weeks, then tested on the AST.
Upon completion of the test, the OFC was collected for rat and human
IL-6 analysis by ELISA, and for measurement of STAT3, ERK1/2, and
AKT phosphorylation by Western blot. Additional animals were used for
immunohistochemistry to define the spread of infection and identify the
cell types infected.
Experiment 4: effect of acute IL-6 administration into the OFC on the
CIC stress-induced reversal learning deficit. To determine whether ele-
vated IL-6 is required throughout the CIC stress treatment or whether
increasing IL-6 in the OFC acutely at the time of testing is sufficient to
attenuate the stress-induced deficit in cognitive function, rats were im-
planted with bilateral guide cannulae aimed at the OFC. After recovery,
animals were exposed to CIC stress, then tested on the AST. Immediately
before the reversal learning stage of the test, 1.0 ng/0.5 l of recombinant
rat IL-6 (R&D Systems) or 0.5 l saline vehicle was injected bilaterally
into the OFC. This dose was chosen based on pilot tests using doses from
0.01 to 1.0 ng.
Experiment 5: effect of acute JAK2/STAT3 inhibition in the OFC on
reversal learning. To determine whether acute inhibition of endogenous
basal JAK2/STAT3 signaling can influence reversal learning, rats were
implanted with bilateral guide cannulae aimed at the OFC. Animals were
allowed at least 2 weeks recovery, then tested on the AST. After comple-
tion of the compound discrimination, rats received bilateral microinjec-
tions into the OFC of vehicle (0.38% EtOH in saline), 37.5 M (9.6 ng) or
75 M (19.3 ng) JSI-124, a JAK/STAT inhibitor with an in vitro IC50 value
between 0.8 and 7.5 M (Sun et al., 2005). Five minutes after injections,
testing resumed with the reversal learning task.
Experiment 6: cellular localization of IL-6 and JAK/STAT expression in
the OFC. To identify the cell types that express IL-6 under basal condi-
tions, naive rats were perfused for dual-fluorescence immunohistochem-
istry to label IL-6 and either NeuN for neurons, GFAP for astrocytes, or
CD11b for microglia. To identify the cell types that demonstrated JAK/
STAT activation after IL-6 overexpression, the AAV-IL-6 virus was in-
jected into the OFC to increase IL-6 expression. Rats were allowed 3
weeks to recover, then perfused for dual-fluorescence immunohisto-
chemistry to colocalize phospho-STAT3 expression with the cell markers
above. To quantify the number of cells expressing each label, two sections
through the OFC were imaged from each rat. For each section, the OFC
was defined as a triangular area with its vertices at the rhinal sulcus, the
medial boundary of the forceps minor, and lateral edge of the forceps
minor. A standard field of view (200 m 2) was positioned within the
center of this area. The total number of cells labeled by each marker were
counted within this field, and the percentages exhibiting coexpression
were calculated.
Results
Experiment 1: chronic immunoneutralization of brain IL-6
impairs reversal learning
To determine whether IL-6 signaling in the brain influences re-
versal learning, chronic intracerebroventricular infusion of a
neutralizing anti-IL-6 antibody or an IgG control antibody was
administered to unstressed control animals or to rats subjected to
CIC stress treatment, which we have shown previously to pro-
duce a deficit in reversal learning (Danet et al., 2010). Three days
after the termination of CIC stress, reversal learning was assessed
using the AST. Our initial hypothesis was that the anti-IL-6 anti-
body would prevent the reversal learning deficit caused by
chronic cold stress. However, the results instead showed that IL-6
neutralization impaired reversal learning in both stressed and
nonstressed animals. There were significant main effects of both
CIC stress and anti-IL-6 antibody administration on the depen-
dent measure of TTC for successful reversal learning on the AST
(Fig. 1a; two-way ANOVA, main effect of stress: F(1,34)  4.222,
p  0.0476; antibody treatment: F(1,34)  10.48, p  0.0027).
Neither stress nor the anti-IL-6 antibody affected TTC during
training or on the simple and compound discrimination test
stages preceding the reversal task (data not shown), suggesting
that there were no nonspecific effects on motivation, learning of
the reward contingencies, or ability to perform the task. To con-
firm the effectiveness of antibody treatment and to identify po-
tential signaling pathways involved in this behavioral effect, we
also measured phosphorylation of STAT3, ERK1/2, and AKT in
the OFC of the same rats. We found that IL-6 neutralization
reduced STAT3 and ERK1/2 activity without affecting AKT. Spe-
cifically, although there was no effect of CIC stress, there was a
significant main effect of antibody treatment on STAT3 phos-
phorylation (Fig. 1b; F(1,30)  8.971, p  0.0055) and ERK1/2
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phosphorylation (Fig. 1c; F(1,32)  5.996, p  0.02), but no effects
on AKT phosphorylation at either the Thr308 (Fig. 1d) or the
Ser473 phosphorylation sites (Fig. 1e). Representative Western
blot images are shown in Figure 1f. Thus, contrary to our original
hypothesis, these results suggest that basal IL-6 signaling, acting
potentially through the JAK/STAT or ERK1/2 pathways, facili-
tates reversal learning capability under both stressed and non-
stressed conditions.
Experiment 2: acute IL-6 inhibition in the OFC, but not the
dorsal striatum, causes a reversal learning deficit
After demonstrating that basal IL-6 facilitates reversal learning,
we next wanted to identify the brain region responsible for this
effect. The neutralizing anti-IL-6 antibody was injected bilater-
ally, directly into the OFC immediately before the reversal learn-
ing stage of the test. As a control to establish anatomical specificity,
another group of rats was injected in the dorsal striatum. Repre-
sentative examples of bilateral guide cannula tracks localized to
the OFC and dorsal striatum are shown in Figures 2a and 2c,
respectively. Injection of the anti-IL-6 antibody into the OFC
impaired reversal learning performance, increasing trials to meet
criterion on the reversal learning task compared with the IgG
control group (Fig. 2b; t(11)  3.309, p  0.007). By contrast, the
anti-IL-6 antibody injection into the dorsal striatum had no effect
on reversal learning (Fig. 2d). Together with the results from
Experiment 1, this suggests that basal IL-6 signaling facilitates
reversal learning specifically in the OFC.
Experiment 3: chronic IL-6 overexpression in the OFC
attenuates the reversal learning deficit caused by CIC stress
The demonstration that IL-6 immunoneutralization impaired
reversal learning in both stressed and nonstressed conditions
raised the possibility that elevating IL-6 in the OFC might
improve cognitive performance that has been compromised
by chronic stress. Thus, we used AAV vector-mediated gene
delivery to increase human IL-6 expression in the OFC and
found that the vector-mediated IL-6 expression attenuated the
reversal learning deficit caused by CIC stress. There was a
significant main effect of CIC stress and a significant interac-
tion between stress and IL-6 overexpression (Fig. 3a; stress:
F(1,24)  6.857, p  0.0151; interaction: F(1,24)  4.742, p 
0.0395). Post hoc analysis indicated that increasing IL-6 ex-
pression in the OFC by AAV-IL-6 had no effect on reversal
learning in unstressed animals, but there was a significant
improvement in reversal learning performance of CIC-
Figure 1. Effect of central IL-6 immunoneutralization on reversal learning and downstream signaling pathways in the OFC. a, Both CIC stress and treatment with an anti-IL-6 antibody (200 ng/d,
i.c.v.) increased trials to meet criterion on the reversal learning stage of the attentional set-shifting test. *p  0.05, main effect compared with IgG control groups. 	p  0.05, main effect compared
with nonstress control groups. b– e, Treatment with the IL-6 antibody decreased STAT3 and ERK1/2 phosphorylation in the OFC without affecting AKT phosphorylation. Fold change relative to No
Stress, IgG Antibody control group. *p  0.05, main effect compared with IgG control groups. f, Representative Western blot images. n  9 –11 per group.
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stressed rats treated with AAV-IL-6 compared with AAV-
GFP-treated controls after CIC stress (Fig. 3a).
To determine which cell types were infected by the viral vec-
tor, we used dual fluorescence immunohistochemistry to label
GFP together with one of three cell-type markers: NeuN for neu-
rons, GFAP for astrocytes, or CD11b for microglia. We found
that GFP colocalized with NeuN, but not GFAP or CD11b, sug-
gesting that the viral vector (AAV5 serotype) exclusively infected
neurons in the OFC (Fig. 3b). Although all GFP-positive cells
expressed NeuN, not all NeuN positive cells expressed GFP, sug-
gesting that only a subpopulation of neurons were infected. At
the site of injection, 40% of neurons expressed GFP. The spread
of infection can be seen in Figure 3c. The bulk of infection was
located in the OFC, between bregma 3.7 and bregma 2.7. How-
ever, a few GFP-positive cells were seen as far anterior as bregma
4.2 and as far posterior as bregma 1.2.
To confirm the effectiveness of viral-mediated gene transfer,
OFC tissue was collected after testing on the AST for analysis by
ELISA and Western blot. The AAV-IL-6 vector increased human
IL-6 protein levels in the OFC in both stressed and unstressed rats
(Fig. 3d; F(1,24)  13.73, p  0.001) without affecting endogenous
rat IL-6 expression (Fig. 3e). Human IL-6 has been shown to
signal through the rat IL-6 receptor (Hoekzema et al., 1991). To
confirm that our overexpression system had functional conse-
quences and to identify the signaling pathways involved, we
measured STAT3, ERK1/2, and AKT
phosphorylation in the OFC by Western
blot. IL-6 overexpression activated the
JAK/STAT pathway in the OFC without
affecting ERK1/2 or AKT. Specifically,
there was a significant main effect of IL-6
overexpression on STAT3 phosphoryla-
tion (Fig. 3f; F(1,24)  43.75, p  0.0001),
but no significant effects on ERK1/2 (Fig.
3g) or AKT phosphorylation (Fig. 3h,i).
Representative Western blot images are
shown in Figure 3j. These results suggest
that IL-6, expressed and presumably se-
creted specifically by neurons in the OFC,
attenuates the detrimental effect of CIC
stress on reversal learning, associated with
activation of the JAK/STAT signaling
pathway.
Experiment 4: acute IL-6
administration into the OFC restores
reversal learning performance that has
been disrupted by CIC stress
In the next experiment, we confirmed and
extended the findings of Experiment 3 by
demonstrating that an acute administra-
tion of exogenous IL-6 into the OFC at the
time of testing was sufficient to reverse the
CIC stress-induced deficit in cognitive
function. There was a significant main
effect of CIC stress and a significant
stress  drug interaction (Fig. 4; stress:
F(1,30)  6.904, p  0.0134; interaction:
F(1,30)  5.685, p  0.0236). Post hoc anal-
ysis shows that IL-6 administration had
no effect in nonstressed animals, but CIC-
stressed rats that received IL-6 required
significantly fewer trials to meet criterion
compared with those injected with vehicle. Together, these re-
sults suggest that increasing IL-6 in the OFC at the time of testing
is sufficient to restore reversal learning capability that was com-
promised by chronic stress.
Experiment 5: inhibition of the JAK/STAT pathway in the
OFC impairs reversal learning
The Western blot results from Experiments 1 and 3 suggested that
IL-6 may act through the JAK/STAT pathway to facilitate reversal
learning. To test this hypothesis, we microinjected a specific JAK/
STAT inhibitor, JSI-124, into the OFC before testing reversal
learning (Fig. 5). Similar to IL-6 immunoneutralization, JAK/STAT
inhibition in the OFC impaired cognitive flexibility. There was a
significant effect of JSI-124 administration on trials to meet criterion
in the reversal learning stage of the AST (one-way ANOVA: F(2,15) 
13.69, p  0.0004). Post hoc analysis suggested that the effect of
JSI-124 was dose-dependent, as only rats receiving the highest dose
were significantly different from vehicle controls. These results, to-
gether with those of the preceding experiments, support the hypoth-
esis that IL-6-induced activation of the JAK/STAT pathway
facilitates cognitive flexibility in the OFC.
Experiment 6: cellular localization of IL-6 and JAK/STAT
To determine which cell types in OFC express endogenous IL-6
under noninflammatory conditions, naive animals were used for
Figure 2. Effect of local IL-6 immunoneutralization on reversal learning performance. a, c, Representative images of cannula
placement and injection sites in the OFC and dorsal striatum, respectively. *Injection site. b, Injection of the anti-IL-6 antibody into
the OFC increased trials to meet criterion on the reversal learning stage of the attentional set-shifting test compared with the IgG
control group. *p  0.05, compared with IgG control group. d, Injection of the anti-IL-6 antibody into the dorsal striatum had no
effect on reversal learning performance. n.s., Not significantly different from IgG control; Cg, cingulate cortex; Fr, frontal cortex; Pir,
piriform cortex; CC, corpus collosum; CPu, caudate–putamen; Acb, nucleus accumbens. n  6 or 7 per group.
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Figure 3. Effect of chronic IL-6 overexpression on reversal learning and downstream signaling pathways in the OFC. a, CIC stress increased trials to meet criterion on the reversal learning task, and
AAV-IL-6 injection into the OFC restored reversal learning performance to nonstress levels. 	p  0.05, main effect compared with no stress control groups. *p  0.05, compared with the
AAV-IL-6-injected animals subjected to CIC stress. b, AAV-GFP exclusively infected neurons, determined by GFP expression seen in neurons but not astrocytes or microglia. Scale bar, 10 m. c,
Representative micrograph showing the extent of infection in the OFC, with corresponding diagrams at AP levels from bregma 3.72 to 3.00 (Paxinos and Watson, 2006). Green represents GFP; red
represents NeuN. d, e, AAV-IL-6 increased the expression of recombinant human IL-6 in the OFC, without affecting endogenous rat IL-6 levels. *p  0.05, main effect compared with AAV-GFP-
infected animals. f–i, AAV-IL-6 injection increased STAT3 phosphorylation in the OFC without affecting ERK1/2 or AKT phosphorylation. Fold change relative to No Stress, AAV-GFP control group.
*p  0.05, main effect compared with AAV-GFP-injected animals. j, Representative Western blot images. fmi, Forceps minor of the corpus callosum; rf, rhinal fissure; aca, anterior commissure; Pir,
piriform cortex. n  7 or 8 per group.
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dual-fluorescence immunohistochemistry to label IL-6 and the
cell markers NeuN, GFAP, or CD11b. Representative images are
shown in Figure 6a– c. Under basal conditions, IL-6 was ex-
pressed by both neurons and astrocytes, but not by microglia.
Approximately 75% of the IL-6-positive cells were neuronal, also
expressing NeuN. A much smaller proportion of IL-6-positive
cells (10%) were astrocytes, also expressing GFAP. Although
the majority of IL-6-positive cells were neurons, only a subpop-
ulation of all NeuN-labeled neurons in the OFC expressed IL-6
(15%).
By contrast, all three cell types examined exhibited STAT3
phosphorylation after chronic IL-6 overexpression in rats in-
fected with the AAV-IL-6 virus in the OFC (Fig. 6d–f). The largest
proportion of phospho-STAT3-positive cells were neurons
(40%). Astrocytes and microglia made a smaller contribution,
30% and 15%, respectively, of phospho-STAT3-positive cells.
These results suggest that under basal, noninflammatory condi-
tions, IL-6 is expressed and presumably secreted primarily by
neurons, and potentially activates JAK/STAT signaling in neu-
rons and astrocytes and, to a lesser extent, microglia. Thus, basal
IL-6 and JAK/STAT signaling in the OFC appears to involve pri-
marily nonimmune cells.
Discussion
Much of the current research on the role of cytokines in higher-
order brain function is based on the hypothesis that the activity of
proinflammatory cytokines, driven to high levels in the brain by
immune activation and inflammation, has detrimental conse-
quences. However, it is becoming increasingly clear that both
proinflammatory and anti-inflammatory cytokines are present in
the brain under nonpathological, noninflammatory conditions
and that these molecules may play an important role in regulating
normal physiological processes. In the current studies, we iden-
tified a novel role for the proinflammatory cytokine IL-6 in facil-
itating reversal learning, a form of cognitive flexibility that is
often impaired in psychiatric disease. We found that neutralizing
IL-6 in the brain impaired reversal learning in both stressed and
nonstressed animals. This effect was localized specifically to the
OFC, as acute microinjections of the IL-6 antibody directly into
the OFC also impaired reversal learning, whereas injections into
the dorsal striatum had no effect. We showed that, under basal
conditions, IL-6 expression, as well as JAK/STAT activation after
chronic IL-6 overexpression, occurred primarily in neurons and,
to a lesser extent, in astrocytes, but not in microglia, the resident
immune cells of the brain. We further showed that inhibiting the
JAK/STAT signaling pathway, a downstream mediator of IL-6
activity, also compromised reversal learning, providing conver-
gent evidence for a role of this cytokine signaling system in facil-
itating cognitive flexibility. These results suggest that, under
basal, noninflammatory conditions, IL-6 and JAK/STAT signal-
ing in the OFC facilitate reversal learning.
We have established previously that CIC stress impairs rever-
sal learning and that this effect can be prevented or reversed by
chronic antidepressant treatment (Danet et al., 2010), providing
a model for the cognitive inflexibility seen in stress-related psy-
chiatric diseases, such as depression. In the current studies, we
also demonstrated that elevating IL-6 in the OFC, either chroni-
cally throughout the stress treatment by local infection with IL-
6-expressing AAV or acutely by local microinjection at the time
of testing, attenuated the cognitive deficit induced by chronic
stress. Thus, these results suggest that, although IL-6 may not play
a role in the mechanism of stress-induced cognitive pathology,
this pathway may represent a novel therapeutic target for treating
cognitive dysfunction associated with psychiatric illnesses, per-
haps specifically in cases where inflammation is not a prominent
factor. Indeed, an important caveat in the present study is that it
does not address a potential role for excessively high IL-6 levels in
possibly contributing to cognitive dysfunction associated with
inflammation.
Although the literature on the effects of cytokines on cogni-
tion is not extensive, our results are in line with previous obser-
vations that IL-6, like other proinflammatory cytokines, can
influence cognition (Yirmiya and Goshen, 2011). Perhaps consis-
tent with its role as both a proinflammatory and anti-inflammatory
cytokine, IL-6 has been shown to have both beneficial and detrimen-
tal effects on cognition. In one study, exogenous IL-6 administra-
tion had no effect in healthy animals (Oitzl et al., 1993), but under
inflammatory conditions, such as aging or after immune stimu-
lation, IL-6 impaired hippocampal-dependent learning and
memory (Sparkman et al., 2006; Dugan et al., 2009). By contrast,
we found in the current studies that chronic IL-6 neutralization
induced a specific deficit in reversal learning and that IL-6 over-
expression attenuated the reversal learning deficit caused by
chronic stress. Likewise, in another study, endogenous IL-6 or
exogenous IL-6 administered before an insult also facilitated cog-
Figure 4. Effect of acute IL-6 injection on reversal learning. CIC stress increased trials to
criterion on the reversal learning stage of the attentional set-shifting test, and an acute micro-
injection of IL-6 (1.0 ng) into the OFC returned performance to nonstress control levels. 	p 
0.05, main effect of CIC stress compared with nonstress controls. *p  0.05 vehicle compared
with IL-6 injections in animals subjected to CIC stress. n  8 or 9 per group.
Figure 5. Effect of JAK/STAT pathway inhibition on reversal learning performance. Microin-
jection of the JAK/STAT inhibitor, JSI-124, into the OFC dose-dependently increased trials to
criterion on the reversal learning task. *p 0.05, compared with vehicle-injected animals. n 
6 per group.
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nitive function (Matsuda et al., 1996;
Baier et al., 2009). Cognitive flexibility
and working memory represent distinct,
sometimes even opposing, cognitive pro-
cesses, mediated by different brain cir-
cuits. In our experiments, acute IL-6 was
administered immediately before testing
on the reversal task, thus avoiding any po-
tential confounding effects on the preced-
ing simple and compound discriminations.
However, these earlier stages of the AST
were also unaffected by the chronic manip-
ulations, suggesting that IL-6 in the OFC
specifically facilitates reversal learning,
rather than affecting learning and mem-
ory processes in general. Thus, the effects
of IL-6 on cognition are complex and may
depend on factors, including the specific
cognitive task, the brain regions involved,
the physiological context, timing and du-
ration of exposure, and IL-6 expression
levels.
IL-6 may exert differential effects (i.e.,
producing deficits when expressed under
inflammatory conditions, but facilitating
function at basal levels), by activating dif-
ferent signaling pathways and/or cell types.
IL-6 can activate three signaling pathways,
JAK/STAT, ERK, and PI3K/AKT, allowing
for alternative responses (Heinrich et al.,
2003). We demonstrated that JAK/STAT
signaling facilitates cognitive flexibility,
suggesting a beneficial role for this path-
way, which is in line with a limited litera-
ture on JAK/STAT signaling in cognition (Chiba et al., 2009; Park
et al., 2013). However, JAK/STAT signaling is not unique to IL-6,
and it is possible that other molecules that activate this pathway
can also influence cognition through JAK/STAT signaling. The
different signaling pathways can also regulate each other and
interact with other signaling pathways, which may occur partic-
ularly when other cytokines are elevated, as occurs in inflamma-
tion (Kumar et al., 1997). Further, astrocytes, neurons, and
microglia have all been shown to produce and respond to IL-6
(Marz et al., 1998; Jankord et al., 2010), so the cell types involved
in IL-6 signaling under different conditions may determine the
functional outcome. For example, nontargeted IL-6 overexpres-
sion in the brain increased the number of excitatory synapses and
mushroom-shaped spines (Wei et al., 2012), whereas IL-6 ex-
pression specifically in astrocytes had detrimental effects on den-
dritic morphology (Campbell et al., 1993). We found that JAK/
STAT signaling was activated primarily in neurons after IL-6
overexpression, and others have demonstrated that IL-6 acting
on neurons can prevent degeneration (Pizzi et al., 2004), pro-
mote neurite outgrowth (Schäfer et al., 1999), and attenuate ex-
citotoxic damage (Wang et al., 2009). It is possible that neuronal
IL-6 acts in an autocrine fashion to have beneficial neuroprotec-
tive effects, whereas induced IL-6 released by astrocytes or micro-
glia under inflammatory conditions may contribute to a more
neurotoxic state.
There are multiple mechanisms by which neuronal IL-6 could
facilitate cognitive flexibility under basal conditions, including its
ability to interact with neurotransmitters, to influence plasticity,
and to regulate neuronal excitability. Reversal learning is facili-
tated by serotonin, a modulatory neurotransmitter targeted in
the treatment of mood and anxiety disorders. Serotonin signaling
in the OFC is required for optimal reversal learning, an effect
mediated in part by cortical serotonin-2A receptors (Danet et al.,
2010; Furr et al., 2012). IL-6 may interact with this neurotrans-
mitter system (e.g., influencing the mechanisms involved in se-
rotonin release, signaling, or metabolism). Further, the JAK/
STAT pathway may be a point of convergence for IL-6 and
serotonin signaling, as the serotonin-2A receptor has been shown
to couple to JAK/STAT in muscle tissue (Guillet-Deniau et al.,
1997). Alternatively, IL-6 and JAK/STAT signaling may both in-
fluence reversal learning by regulating neuronal plasticity. IL-6 is
released during long-term potentiation (Balschun et al., 2004), a
cellular correlate of learning and memory, and can influence den-
dritic and spine morphology (Wei et al., 2012), disruptions of
which have been associated with psychiatric illness, and with def-
icits of cognitive flexibility in animal models (Liston et al., 2006;
Penzes et al., 2011). The JAK/STAT pathway may also be involved
in synaptic plasticity. In addition to genomic effects, STAT pro-
teins have been shown to influence microtubule stability (Ng et
al., 2006) and are localized to the postsynaptic density where they
regulate NMDA-mediated synaptic plasticity (Nicolas et al.,
2012). Finally, the effects of IL-6 and JAK/STAT signaling on
reversal learning may result from the modulation of neuronal
excitability. Prefrontal cortical regions are hypoactive in depres-
sion and other psychiatric disorders associated with executive
dysfunction (Drevets, 2007), and IL-6 can enhance cortical excit-
ability (Garcia-Oscos et al., 2012). Interestingly, this may explain
how low levels of IL-6 facilitate cognitive function whereas higher
Figure 6. Basal IL-6 expression and IL-6 induced STAT3 phosphorylation in the OFC. a, The majority of IL-6-positive cells in the
OFC also expressed the neuronal marker, NeuN. b, A smaller percentage of IL-6-positive cells also expressed the astrocytic marker,
GFAP. c, IL-6 expression was not observed in CD11b-positive microglia. d, The majority of phospho-STAT3-positive cells in the OFC
also expressed the neuronal marker, NeuN. e, In addition, astrocytes labeled with GFAP expressed phospho-STAT3. f, A very small
number of Iba1-positive microglia were observed to express phospho-STAT3 in the OFC. Scale bar, 10 m. n  3 per group.
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levels, which could potentially induce excitotoxicity, can be
detrimental.
Executive dysfunction and associated changes in prefrontal
cortical activity are increasingly recognized as an important com-
ponent of many psychiatric diseases. The mechanisms by which
this dysfunction occurs remain to be elucidated, and current
treatment strategies often fail to resolve the cognitive compo-
nents of such illness (Williams et al., 2000). In the current studies,
we investigated the role of IL-6 and its downstream JAK/STAT
signaling pathway in cognitive function in the OFC. We demon-
strated that basal IL-6 and JAK/STAT signaling facilitates a
translationally relevant form of cognitive flexibility. Some inves-
tigators have proposed that anti-inflammatory drugs may be
beneficial for the treatment of psychiatric illness (Dantzer et al.,
2008). However, our results would suggest that caution is war-
ranted, that a reduction in immune signaling may not be univer-
sally effective, and as shown by others, could even exacerbate
aspects of the disorder or attenuate therapeutic efficacy under
certain conditions (Warner-Schmidt et al., 2011). Indeed, our
data would suggest that, in cases where inflammation is not
prominent, elevating IL-6 and/or JAK2-STAT3 signaling may
improve executive function, which may alleviate other symptoms
and ultimately contribute to a more effective treatment response.
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